Indian Immunologicals signs MoA with ICMR for clinical development of Zika vaccine

IIL partnered with Griffith University, Australia, to develop the codon de-optimized live attenuated Zika vaccine that has completed extensive pre-clinical evaluations and received permission from Indian regulatory authority to produce GMP-grade materials for clinical developmental work.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/7wGqd6W
via